163 related articles for article (PubMed ID: 27364549)
21. Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol.
Stoschitzky K; Stoschitzky G; Brussee H; Bonelli C; Dobnig H
Cardiology; 2006; 106(4):199-206. PubMed ID: 16679760
[TBL] [Abstract][Full Text] [Related]
22. Carvedilol versus Metoprolol for the prevention of atrial fibrillation after off-pump coronary bypass surgery: rationale and design of the Carvedilol or Metoprolol Post-Revascularization Atrial Fibrillation Controlled Trial (COMPACT).
Kamei M; Morita S; Hayashi Y; Kanmura Y; Kuro M
Cardiovasc Drugs Ther; 2006 Jun; 20(3):219-27. PubMed ID: 16794788
[TBL] [Abstract][Full Text] [Related]
23. The comparative effects of long-term carvedilol versus bisoprolol therapy on QT dispersion in patients with chronic heart failure.
Aygul N; Ozdemir K; Duzenli MA; Aygul MU
Cardiology; 2009; 112(3):168-73. PubMed ID: 18654081
[TBL] [Abstract][Full Text] [Related]
24. Carvedilol is effective and safe in combination with bepridil for persistent atrial fibrillation and decreases the QT prolongation induced by bepridil therapy.
Kawamura M; Munetsugu Y; Tanno K; Kobayashi Y
J Cardiovasc Pharmacol; 2013 Jan; 61(1):77-82. PubMed ID: 23107870
[TBL] [Abstract][Full Text] [Related]
25. Troponin I levels in permanent atrial fibrillation-impact of rate control and exercise testing.
Horjen AW; Ulimoen SR; Enger S; Norseth J; Seljeflot I; Arnesen H; Tveit A
BMC Cardiovasc Disord; 2016 May; 16():79. PubMed ID: 27142292
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of a new vasodilating beta-blocking agent, carvedilol, in exertional angina using holter monitoring.
Kishida H; Saito T; Fukuma N; Hata N; Suzuki T; Ohtsu F
Jpn Heart J; 1990 Jul; 31(4):449-60. PubMed ID: 1977939
[TBL] [Abstract][Full Text] [Related]
27. Relation of risk factors with response to carvedilol in heart failure with preserved ejection fraction - a report from the Japanese Diastolic Heart Failure Study (J-DHF).
Yamamoto K; Origasa H; Suzuki Y; Takahashi T; Shinozaki T; Watanabe T; Sakata Y; Izumi C; Taira K; Hori M;
J Cardiol; 2014 Jun; 63(6):424-31. PubMed ID: 24286855
[TBL] [Abstract][Full Text] [Related]
28. Beta-blockade and A1-adenosine receptor agonist effects on atrial fibrillatory rate and atrioventricular conduction in patients with atrial fibrillation.
Corino VD; Holmqvist F; Mainardi LT; Platonov PG
Europace; 2014 Apr; 16(4):587-94. PubMed ID: 23989533
[TBL] [Abstract][Full Text] [Related]
29. Comparison of effectiveness of carvedilol versus bisoprolol for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation.
Katritsis DG; Panagiotakos DB; Karvouni E; Giazitzoglou E; Korovesis S; Paxinos G; Anagnostopoulos CE; Camm AJ
Am J Cardiol; 2003 Nov; 92(9):1116-9. PubMed ID: 14583369
[TBL] [Abstract][Full Text] [Related]
30. Optimal beta-blocker for prevention of atrial fibrillation after on-pump coronary artery bypass graft surgery: carvedilol versus metoprolol.
Haghjoo M; Saravi M; Hashemi MJ; Hosseini S; Givtaj N; Ghafarinejad MH; Khamoushi AJ; Emkanjoo Z; Fazelifar AF; Alizadeh A; Sadr-Ameli MA
Heart Rhythm; 2007 Sep; 4(9):1170-4. PubMed ID: 17765616
[TBL] [Abstract][Full Text] [Related]
31. A common β1-adrenergic receptor polymorphism predicts favorable response to rate-control therapy in atrial fibrillation.
Parvez B; Chopra N; Rowan S; Vaglio JC; Muhammad R; Roden DM; Darbar D
J Am Coll Cardiol; 2012 Jan; 59(1):49-56. PubMed ID: 22192668
[TBL] [Abstract][Full Text] [Related]
32. Titration of carvedilol in elderly heart failure patients.
Lawless CE; Tamlyn T; Shah R; Karim FM; Khan E; Creech S
Am J Geriatr Cardiol; 2005; 14(5):230-5. PubMed ID: 16247281
[TBL] [Abstract][Full Text] [Related]
33. Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: the MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy).
Ruwald MH; Abu-Zeitone A; Jons C; Ruwald AC; McNitt S; Kutyifa V; Zareba W; Moss AJ
J Am Coll Cardiol; 2013 Oct; 62(15):1343-50. PubMed ID: 23770172
[TBL] [Abstract][Full Text] [Related]
34. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial.
Hori M; Sasayama S; Kitabatake A; Toyo-oka T; Handa S; Yokoyama M; Matsuzaki M; Takeshita A; Origasa H; Matsui K; Hosoda S;
Am Heart J; 2004 Feb; 147(2):324-30. PubMed ID: 14760332
[TBL] [Abstract][Full Text] [Related]
35. Non-invasive assessment of the effect of beta blockers and calcium channel blockers on the AV node during permanent atrial fibrillation.
Sandberg F; Corino VD; Mainardi LT; Ulimoen SR; Enger S; Tveit A; Platonov PG; Sörnmo L
J Electrocardiol; 2015; 48(5):861-6. PubMed ID: 26275982
[TBL] [Abstract][Full Text] [Related]
36. A placebo-controlled, double-blind, randomized, multicenter study to assess the effects of dronedarone 400 mg twice daily for 12 weeks on atrial fibrillation burden in subjects with permanent pacemakers.
Ezekowitz MD; Ellenbogen KA; DiMarco JP; Kaszala K; Boddy A; Geba GP; Koren A
J Interv Card Electrophysiol; 2015 Mar; 42(2):69-76. PubMed ID: 25638303
[TBL] [Abstract][Full Text] [Related]
37. Safety and efficacy of carvedilol therapy for patients with dilated cardiomyopathy secondary to muscular dystrophy.
Rhodes J; Margossian R; Darras BT; Colan SD; Jenkins KJ; Geva T; Powell AJ
Pediatr Cardiol; 2008 Mar; 29(2):343-51. PubMed ID: 17885779
[TBL] [Abstract][Full Text] [Related]
38. Carvedilol titration in patients with congestive heart failure receiving inotropic therapy.
Kumar A; Choudhary G; Antonio C; Just V; Jain A; Heaney L; Papp MA
Am Heart J; 2001 Sep; 142(3):512-5. PubMed ID: 11526366
[TBL] [Abstract][Full Text] [Related]
39. Dose Related Patterns of Ventricular Arrhythmia due to Carvedilol Withdrawal in Patients with Systolic Heart Failure.
Kido K; Brouse SD; Macaulay TE; Charnigo RJ; Anaya P
Curr Drug Saf; 2015; 10(3):227-33. PubMed ID: 25921410
[TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of carvedilol for heart failure in children and patients with congenital heart disease.
Nishiyama M; Park IS; Yoshikawa T; Hatai Y; Ando M; Takahashi Y; Mori K; Murakami Y
Heart Vessels; 2009 May; 24(3):187-92. PubMed ID: 19466519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
